A Better Tomorrow
Synergy Therapeutics
Hematopoietic Stem Cell Therapies
Design stunning decks using user-friendly editor, customizable templates and layouts.
Mesenchymal Stem Cell Therapies
Multipotent stem cells with regenerative and immunomodulatory properties
Targeted Stem Cell Delivery Systems
Precision targeting of stem cells to tumor sites and metastases
Phases of clinical trials
Phases
Phase I trials test new cancer drugs in a small group to find safe doses for further testing.
Phase II trials test new cancer drugs in specific groups to see if they work, using innovative methods to measure response rates and survival without progression.
Phase III trials decisively compare new drugs to standard care, using large groups and strict randomization to find survival differences.
Clinical
Clinical Trials
Dedicated to pushing boundaries of stem cell research
Developing cutting-edge therapies for improved cancer outcomes
World-class scientists harnessing transformative stem cell technology
New Ways To Tackle Disease
Virtually every human disease begins with cells. We understand that each disease is unique, and finding the best treatment requires a deep understanding of its genetic and cellular underpinnings.
Inspired By Vision
The era of engineered cell therapies can transform the field of healthcare. We aim to deliver medicines that strike at the heart of disease, meaningfully improve the lives of patients and their families, and are broadly accessible to the people who need them.
Our Mission
Improve lives of cancer patients
Develop innovative stem cell therapies
Offer new treatment possibilities and better outcomes
Unleash the full power of Stem Cell
Synergy is a leading biopharmaceutical company at the forefront of stem cell therapy innovation. With a deep commitment to scientific excellence and a patient-centric approach, we strive to unlock the full potential of stem cells to develop personalized and effective cancer treatments.
Recognized by multiple awards for scientific innovation
3
Therapies in Phase 3 clinical trials
+20
years of experience in stem cell research and development
